$1.19
At close: May 5 EDT
$1.18
-0.01-0.84%
Pre-Market: 5:04 PM EDT
Comments
Loading...
Channel Therapeutics Stock Guidance | AMEX:CHRO | Benzinga
Channel Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Channel Therapeutics Corp (CHRO) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Channel Therapeutics (CHRO)?
There have been no specific sales or earnings guidance reported for Channel Therapeutics in recent months.
Browse guidance and forecast on all stocks.
